Crawford FDA Confirmation Vote Expected By Mid-May
This article was originally published in The Pink Sheet Daily
The vote would come just over a month after an April 13 Senate Health Committee vote on Crawford's nomination for FDA commissioner was abruptly cancelled. Barr expects FDA approval of its Rx-to-OTC switch application for Plan B once a permanent commissioner is in place.
You may also be interested in...
FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years. This is Part II in the series.
With two landmark advisory committee meetings coming up, the Pink Sheet reflects on some of the most memorable panel meetings over the last 20 years.